Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Lannett Buys UCB's U.S. Generics Division for $1.23 Billion
Lannett Buys UCB's U.S. Generics Division for $1.23 Billion
Lannett Buys UCB's U.S. Generics Division for $1.23 Billion
Submitted by
admin
on September 2, 2015 - 5:15pm
Source:
Bloomberg
News Tags:
Lannett
UCB Pharma
generics
M&A
Headline:
Lannett Buys UCB's U.S. Generics Division for $1.23 Billion
Do Not Allow Advertisers to Use My Personal information
